These results collectively suggest that high SETDB1 expression is associated with a proliferative, undifferentiated phenotype in HCC, characterized by increased genomic instability and the upregulation of repair and checkpoint mechanisms. This evidence concerns the gene SETDB1 and hepatocellular carcinoma.